MRD Monitoring in Acute Lymphoblastic Leukemia
0 Bekeken
• 06/15/23
0
0
insluiten
administrator
abonnees
In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties